Acute Exposure to European Viper Bite in Children: Advocating for a Pediatric Approach.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
02 05 2021
Historique:
received: 16 04 2021
revised: 29 04 2021
accepted: 30 04 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 1 7 2021
Statut: epublish

Résumé

Viper bite is an uncommon but serious cause of envenoming in Europe, especially in children. Our study aim is to better describe and analyze the clinical course and treatment of viper bite envenoming in a pediatric population. We retrospectively reviewed 24 cases of pediatric viper bites that were admitted to the Pediatric Emergency Department and the Pediatric Intensive Care Unit of the Bambino Gesù Children Hospital in Rome between 2000 and 2020. Epidemiological characteristics of the children, localization of the bite, clinical and laboratory findings, and treatment approaches were evaluated. The median age of the patients was 4.2 years, with male predominance. Most cases of viper bite occurred in the late summer. Most patients required admission to the ward for prolonged observation. The most common presenting signs were pain, local oedema, and swelling. Patients with a high severity score also had a significantly higher white blood cell count and an increase of INR, LDH, and CRP levels. No fatality was reported. Viper bite envenomation is a rare pediatric medical emergency in Italy but may sometimes be severe. A new pediatric severity score may be implemented in the screening of children with viper bites to favor a selective and prompt administration of antivenom.

Identifiants

pubmed: 34063282
pii: toxins13050330
doi: 10.3390/toxins13050330
pmc: PMC8170888
pii:
doi:

Substances chimiques

Antivenins 0
Viper Venoms 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Rev Dis Primers. 2017 Sep 14;3:17063
pubmed: 28905944
Toxicon. 2012 Sep 15;60(4):712-8
pubmed: 22465493
Pediatr Emerg Care. 2012 Jul;28(7):650-4
pubmed: 22743748
Clin Toxicol (Phila). 2019 Nov 14;:1-2
pubmed: 31724448
Toxicon. 2013 Dec 15;76:206-13
pubmed: 24125660
Crit Care Med. 2003 May;31(5):1449-53
pubmed: 12771617
Toxicon. 1992 May-Jun;30(5-6):599-609
pubmed: 1519251
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2247-2260
pubmed: 32530549
Toxicon. 1964 Jun;15:5-41
pubmed: 14302278
Clin Toxicol (Phila). 2014 Apr;52(4):269-76
pubmed: 24708390
Lancet. 2019 Jun 1;393(10187):2175
pubmed: 31162065
Clin Toxicol (Phila). 2012 Mar;50(3):189-96
pubmed: 22372786
PLoS Negl Trop Dis. 2009 Dec 22;3(12):e569
pubmed: 20027216
Clin Toxicol (Phila). 2017 Jul;55(6):557-568
pubmed: 28349771
Clin Toxicol (Phila). 2020 Nov;58(11):1050-1057
pubmed: 32134691
Eur Rev Med Pharmacol Sci. 2015;19(14):2711-6
pubmed: 26221904
Arch Dis Child. 2021 Jan;106(1):14-19
pubmed: 33115713
Saudi J Kidney Dis Transpl. 2015 Mar;26(2):335-8
pubmed: 25758885
Toxins (Basel). 2016 Mar 26;8(4):93
pubmed: 27023608
Presse Med. 1999 Nov 13;28(35):1929-34
pubmed: 10598149
Eur Rev Med Pharmacol Sci. 2014;18(4):485-92
pubmed: 24610614
J Thromb Haemost. 2018 Feb;16(2):196-208
pubmed: 29316202
Arch Dis Child. 2017 May;102(5):445-449
pubmed: 27806970
J Accid Emerg Med. 1999 Nov;16(6):458
pubmed: 10572830
Toxins (Basel). 2021 Mar 13;13(3):
pubmed: 33805701
Haematologica. 2015 Aug;100(8):1045-50
pubmed: 26001789
Toxicon. 2015 Dec 15;108:97-103
pubmed: 26454165

Auteurs

Marco Marano (M)

Pediatric Intensive Care Unit, Pediatric Clinical Toxicology Center, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Mara Pisani (M)

Department of Emergency, Acceptance and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Giorgio Zampini (G)

Pediatric Intensive Care Unit, Pediatric Clinical Toxicology Center, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Giuseppe Pontrelli (G)

Clinical Trial Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Marco Roversi (M)

Clinical Trial Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH